title: Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease.
authors.affiliation: Heart Center of Los Angeles, Los Angeles, California, USA.
authors.forename: N E
authors.initials: NE
authors.lastname: Lepor
authors.forename: S B
authors.initials: SB
authors.lastname: Gross
authors.forename: W L
authors.initials: WL
authors.lastname: Daley
authors.forename: B A
authors.initials: BA
authors.lastname: Samuels
authors.forename: M J
authors.initials: MJ
authors.lastname: Rizzo
authors.forename: S P
authors.initials: SP
authors.lastname: Luko
authors.forename: A
authors.initials: A
authors.lastname: Hickey
authors.forename: N A
authors.initials: NA
authors.lastname: Buchbinder
authors.forename: T Z
authors.initials: TZ
authors.lastname: Naqvi
mesh_terms: D001022:Aortic Valve Insufficiency / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000503:physiopathology; D001067:Appetite Depressants / Q000008:administration & dosage / Q000009:adverse effects*; D001783:Blood Flow Velocity / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D018618:Echocardiography, Doppler, Color; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D005277:Fenfluramine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000503:physiopathology; D009200:Myocardial Contraction / Q000187:drug effects; D019370:Observation; D015588:Observer Variation; D010645:Phentermine / Q000008:administration & dosage / Q000009:adverse effects*; D012189:Retrospective Studies; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D016278:Ventricular Function, Right / Q000187:drug effects
chemical_list: D001067:Appetite Depressants; D005277:Fenfluramine; D010645:Phentermine; D017367:Selective Serotonin Reuptake Inhibitors